PP
XBIT icon

Paloma Partners’s XBiotech XBIT Stock Holding History

Paloma Partners’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-24,496
Closed -$260K – 2267
2020
Q1 		$260K Buy
+24,496
New +$399K 0.01% 763
2018
Q4 		– Sell
-10,741
Closed -$34K – 1834
2018
Q3 		$34K Sell
10,741
-78,284
-88% -$305K ﹤0.01% 1478
2018
Q2 		$399K Buy
89,025
+73,652
+479% +$333K 0.01% 1133
2018
Q1 		$82K Sell
15,373
-23,997
-61% -$111K ﹤0.01% 1849
2017
Q4 		$155K Buy
+39,370
New +$166K ﹤0.01% 1761

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Paloma Partners's XBIT Position: Q2 2020 in Review

Paloma Partners sold out of XBiotech (XBIT) in Q2 2020, closing a stake of 24,496 shares — an estimated $260K sold.

Paloma Partners first reported a position in XBIT in Q4 2017 and held it in 5 quarters. The position peaked at $399K in Q2 2018. 65 funds tracked by Wall St. Rank hold XBIT as of Q2 2020.

  • Paloma Partners reported no remaining XBiotech position as of Q2 2020 after selling out during the quarter.
  • Paloma Partners sold 24,496 XBiotech shares in Q2 2020, an estimated $260K.
  • Paloma Partners first reported a position in XBiotech in Q4 2017 and held it in 5 quarters.
  • Paloma Partners's XBiotech position peaked at $399K in Q2 2018.
  • 65 funds tracked by Wall St. Rank held XBiotech as of Q2 2020.

Based on Paloma Partners's 13F filing for Q2 2020, filed 14 Aug 2020.